Skip to main content
MLYS filings

Corporate insider profile

Jon Congleton Filing Activity

Latest reported as Chief Executive Officer of Mineralys Therapeutics, Inc. (MLYS).

Purchase filings
0
Reported companies
1
Net open-market value
-$421,979.27
Latest transaction
Apr 13, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 13, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Executive OfficerSale15,730$26.83$421,979